Can inflammatory cytokines inhibit deiodinase activity and lower T4-to-T3 conversion?

The relationship between systemic inflammation and thyroid hormone metabolism is well-documented, specifically through the inhibition of the enzymes responsible for hormone activation. This phenomenon, often referred to as Non-Thyroidal Illness Syndrome (NTIS) or "Low T3 Syndrome," is frequently observed in patients with acute or chronic inflammatory conditions.

Clinical evidence

Peripheral thyroid hormone metabolism is significantly altered during inflammatory states. In clinical settings, there is a clear inverse relationship between serum cytokine levels and the T3:T4 ratio.

• Disease Markers: Lower T3:T4 ratios consistently correlate with elevated inflammatory markers such as C-reactive protein (CRP) and ferritin.
• Outcome Prediction: In critical care scenarios—including sepsis, heart failure, and COVID-19—low T3 levels are independent predictors of mortality. Research indicates that up to 86.5% of critically ill patients exhibit this low T3 profile, reflecting impaired peripheral conversion rather than primary thyroid gland failure.

Mechanistic explanations

Inflammatory cytokines, specifically Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-α), and Interleukin-1 beta (IL-1β), disrupt the T4-to-T3 conversion process through several convergent pathways:

• Transcriptional Suppression: Cytokines activate signaling pathways like NF-κB, which directly interfere with the transcription of deiodinase genes. This reduces the mRNA expression and activity of type 1 (D1) and type 2 (D2) deiodinases, the primary enzymes that convert inactive T4 into active T3.
• Oxidative Stress: Inflammation drives the production of reactive oxygen species (ROS). This oxidative stress creates a redox imbalance that depletes thiol cofactors necessary for the catalytic cycle of selenocysteine-containing deiodinases.
• Enzymatic Shifting: While D1 and D2 are suppressed, inflammation often upregulates the type 3 deiodinase (D3) in immune cells. D3 inactivates thyroid hormones, further depleting T3 levels by favoring the production of reverse T3 (rT3).

Bottom line

Strong scientific evidence supports the claim that inflammatory cytokines inhibit D1 and D2 activity while promoting D3-mediated inactivation. This shift lowers T4-to-T3 conversion, resulting in reduced intracellular T3 signaling and availability during systemic illness.